Table 3.

Cross-validated difference in the c-indices comparing the nonfasting triglyceride cutpoint of 175 mg/dL with the other proposed cutpoints of 180 and 200 mg/dL in multivariable models using bootstrapping methodology.a

Modelc-Indexc-Index
175 mg/dL180 mg/dLMean difference (95% CI)175 mg/dL200 mg/dLMean difference (95% CI)
1b0.7830.7820.001 (−0.005 to 0.010)0.7830.7730.010 (−0.005 to 0.026)
2c0.7880.7870.001 (−0.005 to 0.010)0.7880.7790.008 (−0.004 to 0.026)
3d0.8130.8110.002 (−0.003 to 0.010)0.8130.8020.011 (0.000 to 0.028)
  • a Risk estimated at 8 years of follow-up. To convert triglyceride concentrations to mmol/L, multiply by 0.0113.

  • b Adjusted for age, history of hypertension, smoking, use of hormone therapy, and postmenopausal status.

  • c Adjusted for covariates in model 1 plus total cholesterol and HDL-C.

  • d Adjusted for covariates in model 2 plus diabetes mellitus, BMI, and hsCRP.